Evidence map›Paper›PMID 41606419›Full record

Trial reportActa physiologica (Oxford, England)2026

Functional Training Mitigates Reduced Circulating Indole-3-Lactate Levels in Persons With Relapsing-Remitting Multiple Sclerosis.

Tiffany Wences Chirino, Frederike Adammek, Sergen Belen, Matteo Winker, Sebastian Proschinger, Annette Rademacher, Marit L Schlagheck, Alexander Schenk, Marie Kupjetz, David Walzik and 8 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Acta physiologica (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Tiffany Wences ChirinoSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0002-6153-0705
Frederike AdammekSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0009-0005-2519-4360
Sergen BelenSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0001-9074-3198
Matteo WinkerSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.
Sebastian ProschingerSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0001-8173-1515
Annette RademacherAsklepios MVZ Bayern GmbH, Cham, Germany.
Marit L SchlagheckSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0002-8913-6080
Alexander SchenkSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0002-3122-714X
Marie KupjetzSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0002-1816-8595
David WalzikSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0002-9577-1435
Clemens WarnkeDepartment of Neurology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0002-3510-9255
Marcel ReuterGerman University of Applied Sciences for Prevention and Health Management, Saarbrücken, Germany.
Friederike RosenbergerGerman University of Applied Sciences for Prevention and Health Management, Saarbrücken, Germany.
Tim MeyerInstitute of Sports and Preventive Medicine, University of Saarland, Saarbrücken, Germany.
Adrian McCannBevital AS, Bergen, Norway.ORCID https://orcid.org/0000-0002-5728-5321
Per Magne UelandBevital AS, Bergen, Norway.ORCID https://orcid.org/0000-0002-1903-0571
Niklas JoistenSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0002-9947-8746
Philipp ZimmerSports Medicine Research Group, Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0001-9631-4503

Funding

German Academic Exchange Service 91865036Marga und Walter Boll-Stiftung 210-06.01-19
6 · The paper itself

Abstract

aimIndoles are tryptophan (Trp)-derived metabolites that are produced by the gut microbiota and may influence the gut-microbiota-brain axis in multiple sclerosis (MS). Indole-3-lactate (ILA) is reduced in persons with MS and improves MS clinical scores in animal models via its anti-inflammatory remyelinating properties. The ILA/indole-3-acetate (IAA) (ILA/AA) index is considered a neuroprotection index. Physical exercise and diet can modify gut microbiota and indole metabolism.

methodsThis secondary analysis of a randomized control trial aimed to assess the effects of acute and chronic exercise on serum indoles in relapsing-remitting MS (RRMS). Thirty-one RRMS patients (≥ 70% session attendance) completed a 10 week multimodal functional training (60 min, 3×/week) vs. a waitlist control group. Blood samples were collected at baseline and compared to a matched healthy control group, and after 10 weeks for the assessment of chronic effects. Additionally, acute effects of a single bout of exercise were assessed with a blood sample before, during, and immediately after one interim training session. Serum indole concentrations were measured using LC-MS/MS.

resultsBaseline indole levels in RRMS patients differed from those of matched healthy controls, and reduced ILA levels were observed. The 10 week intervention increased the ILA/IAA index, while a single exercise bout induced an increase in both ILA and ILA/IAA.

conclusionMultimodal functional training over 10 weeks led to an improved ILA/IAA index suggesting a neuroprotective shift in gut microbiota composition, and a single bout acutely increases the circulating level of ILA. STUDY REGISTRATION NUMBER: DRKS00017091.

Indexed as

ExerciseExercise TherapyIndolesMultiple Sclerosis, Relapsing-RemittingAdultFemaleGastrointestinal MicrobiomeHumansMaleMiddle Agedindole-3-lactic acidIndolesexercisegut microbiotaindolesmultiple sclerosistryptophan

Identifiers

PMID41606419
PMCPMC12852534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.